1 Polen Capital Idexx Laboratories Trades
Polen Capital acquired 1.2M Idexx Laboratories shares worth $758M. That's 2.30% of their equity portfolio (20th largest holding). The investor owns 1.46% of the outstanding Idexx Laboratories stock. The stake costed the investor $572M, netting the investor a gain of 33% so far.
News about Idexx Laboratories, Inc. and Polen Capital
IDEXX Laboratories (IDXX) Rebounded After Significant Drawdown From July Highs
Conestoga Capital Advisors, an asset management company, released its ¡°Mid Cap Strategy¡± fourth-quarter 2023 investor letter. A copy of the same can be downl...
Should You Add IDEXX Laboratories (IDXX) to Your Portfolio?
TimesSquare Capital Management, an equity investment management company, released its ¡°U.S. Mid Cap Growth Strategy¡± third-quarter investor letter. A copy of...
Brinker Capital Investments LLC Reduces Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Brinker Capital Investments LLC lessened its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX ¨C Get Rating) by 3.4% during the 4th quarter, Holdin...
LGT Capital Partners LTD. Decreases Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
LGT Capital Partners LTD. trimmed its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 3.0% in the third quarter, according to its most recent...